Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06303869 · ClinicalTrials.gov registry record · NA
Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke
A NA study of Stroke and Cardiovascular Diseases, sponsored by Jorge Gonzalez-Martinez.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT06303869: Recruiting NA study of Stroke and Cardiovascular Diseases, sponsored by Jorge Gonzalez-Martinez.
NCT06303869 is a NA study of Stroke and Cardiovascular Diseases that is actively recruiting participants, run by Jorge Gonzalez-Martinez. The registered enrollment target is 10 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06303869, a NA study of Stroke and Cardiovascular Diseases, is actively recruiting participants, sponsored by Jorge Gonzalez-Martinez.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to verify whether the use of deep brain stimulation can improve motor function of the hand and arm and speech abilities for people following a stroke. Participants will undergo a surgical procedure to implant deep brain stimulation electrode leads. The electrodes will be connected to external stimulators and a series of experiments will be performed to identify the types of movements that the hand and arm can make and how speech abilities are affected by the stimulation. The implant will be removed after less than 30 days. Results of this study will provide the foundation for future studies evaluating the efficacy of a minimally-invasive neuro-technology that can be used in clinical neuro-rehabilitation programs to restore speech and upper limb motor functions in people with subcortical strokes, thereby increasing independence and quality of life.
Primary Outcome
The investigators will quantify the safety of DBS to treat post-stroke speech and upper-limb motor deficits. For this, the investigators will record all adverse events for the entire study duration. The study is considered successful if no serious adverse events related to the use of deep brain stimulation are reported.
Conditions Studied
Interventions
- DEVICE Deep Brain Stimulation (DBS) of the Motor Thalamus
Study Locations (1)
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2025-06-20 |
| Est. Completion | 2029-12 |
| Phase | NA |
What NCT06303869 shows while recruiting
NCT06303869 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower).
The record links to 5 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Deep Brain Stimulation (DBS) of the Motor Thalamus is the first listed.
NCT06303869 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06303869 about?
NCT06303869 is a clinical study titled "Deep Brain Stimulation Motor Ventral Thalamus (VOP/VIM) for Restoration of Speech and Upper-limb Function in People With Subcortical Stroke". The goal of this study is to verify whether the use of deep brain stimulation can improve motor function of the hand and arm and speech abilities for people following a stroke. Participants will undergo a surgical procedure to implant deep brain stimulation electrode leads. The electrodes will be co...
What is the current status of trial NCT06303869?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-06-20. Estimated completion is 2029-12.
What conditions does trial NCT06303869 study?
This clinical trial studies the following conditions: Stroke, Cardiovascular Diseases, Nervous System Diseases, Central Nervous System Diseases, Brain Disease.
What interventions are being tested in trial NCT06303869?
The interventions under investigation include: Deep Brain Stimulation (DBS) of the Motor Thalamus (DEVICE).
Who is sponsoring clinical trial NCT06303869?
This trial is sponsored by Jorge Gonzalez-Martinez, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06303869 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06303869's enrollment target sits among peer trials
10 415th of 454 higher than 30 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
-
Safety and Feasibility of an ExoNET for Supination Assistance for Stroke Survivors
RECRUITING · NA
-
Alternative Therapies for Improving Physical Function in Individuals With Stroke
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
- NCT01870752 · 10 participants · NA
Ovarian Tissue Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI